Isolation of selenite reducing estuarine bacteria and it’s MIC for selenite
Morphologically distinct 50 discrete brick red bacterial colonies were obtained after plating the samples on ZMA with 2mM Na2SeO3 which were considered for further studies (Supplementary Fig. 1). These selected bacterial isolates did not show any brick red pigmentation upon streaking on ZMA plates without Na2SeO3 (Supplementary Fig. 2). The Mandovi estuary of Goa is contaminated with various metals and metalloids including selenium due to numerous anthropogenic and industrial activities such as shipping, tourism, mining and construction. It has already been reported that various bacterial isolates from Mandovi estuary possess resistance as well as cross-resistance to iron, manganese, cobalt, copper, zinc, lead, chromium, mercury, tributyltin and selenite (Khanolkar et al. 2015; Sunitha et al. 2015; Srivastava and Kowshik 2016; Naik and Dubey 2017; Samant et al. 2018).
Out of fifty, 20 bacterial colonies exhibiting MIC greater than 100 mM Na2SeO3 were selected for further studies. Estuarine bacterial strain GUSDM4 showing highest MIC of 101 mM in liquid medium for Na2SeO3 was selected for further characterization. Selenite reducing strain GUSDM4 showed exceptionally highest MIC of 101 mM for Na2SeO3 as compared to previously reported strains of bacteria. For instance, Idiomarina sp. isolated from the banks of Mandovi estuary, Goa, India showed a MIC of 10 mM for selenite (Srivastava and Kowshik 2016) which is 10 times lower than the present study.
Identification of selenite reducing bacterial strain GUSDM4
The bacterial strain GUSDM4 was found to be Gram-negative, motile, rod-shaped, catalase, nitrate and oxidase positive aerobic bacteria. 16S rRNA gene sequencing and sequence comparison against GenBank database using NCBI-BLAST search, strain GUSDM4 was identified as Halomonas venusta (accession number: MG430411). The dendrogram analysis revealed phylogenetic relatedness with other species of Halomonas (Fig. 1).
Strain GUSDM4 was identified as Halomonas venusta. Interestingly, members belonging to family Halomonadaceae are characterized by high salt tolerance (5-25% NaCl) and survival at low to high temperatures (4-40 °C). These characteristics make it a remarkable candidate for selenite bioremediation in various habitats ranging from estuaries to saline lakes and oceans. There are very few reports on selenite reduction by genus Halomonas and this is the first detailed study on selenite reduction by Halomonas venusta isolated from Mandovi estuary showing the highest level of selenite resistance.
Selenite uptake studies using bacterial strain GUSDM4
Selenite uptake by Halomonas venusta strain GUSDM4 grown in ZMB with 2 and 4mM Na2SeO3 was observed during the early log phase of growth (2 h) with a steady increase during the mid-log phase. At mid log phase (26 h), a 50% reduction of selenite was observed. However, 93% and 96% utilization of selenite was achieved at the end of the stationary growth phase for 4 mM and 2 mM respectively (Fig. 2). The uptake studies also revealed significant ability of the strain GUSDM4 to reduce 93% of selenite to elemental selenium during the late stationary phase (58 h) of growth. It's worth mentioning that the previous study on Rhodospirillum rubrum showed selenite reduction at the commencement of the stationary phase which is non-favaourable and also contradictory to the current study (Kessi et al. 1999). Thus, further strengthening its potential to be used for various biotechnological applications including nanoparticle biosynthesis.
Biosynthesis and localization of SeNPs by Halomonas venusta strain GUSDM4
Selenite reduction to elemental Se using strain GUSDM4 was evident by the colour change in the medium from yellow to brick red in the flask with 2 mM Na2SeO3. Whereas, control flask without Na2SeO3 and cell free supernatant with 2 mM Na2SeO3 did not show any brick red colouration thus, confirming intracellular synthesis of SeNPs (Supplementary Fig. 3). It was found that in the presence of selenite H. Venusta strain GUSDM4 demonstrated electron dense deposits throughout the periplasm which was distinctly absent in the control cells. Moreover, intracellular spherical deposits of SeNPs were also visible within the bacterial periplasm (Fig. 3 a, b). Halomonas venusta strain GUSDM4 successfully synthesized Se nanoparticles intracellularly which was initiated within 4 h of the growth phase and was confirmed from a characteristic at 265 nm using UV-Vis spectrophotometry.
The intracellular periplasmic nanoparticle synthesis was further confirmed using TEM analysis which exclusively demonstrated biosynthesis in exposed bacterial cells. Previously, halophilic bacteria namely Bacillus selenitireducens, Selenihalanaerobacter shriftii, Sulfospirillum barnesii, Bacillus megaterium, Bacillus cereus and Idiomarina sp. PR58-8 have been reported for SeNPs biosynthesis (Dhanjal and Cameotra 2010; Forootanfar et al. 2014; Srivastava and Kowshik 2016; Samant et al. 2018). Moreover, similar observation of periplasmic spherical nano-Se biosynthesis has also been reported in strain Se-1-1 belonging to Pseudoalteromonas sp. (Rathgeber et al. 2002). We have reported for the first time intracellular biosynthesis of SeNPs by the marine bacterium Halomonas venusta.
Optimization and time course study of SeNPs biosynthesis
Optimization of SeNPs biosynthesis with respect to pH, temperature and Na2SeO3 was studied during intracellular synthesis. The optimum pH, temperature and Na2SeO3 for SeNPs biosynthesis were 7, 25 °C and 4 mM respectively (Fig. 4 a, b, c). Time course study of SeNPs further revealed that the biosynthesis was initiated during early log phase (i.e. 4 h) which was evident from the colour change in the media and a distinctly sharp peak at 265 nm. Biosynthesis of SeNPs was time-dependent reaching maxima at 34 h of bacterial growth (Fig. 4d).
It was interesting to note that the estuarine strain GUSDM4 could synthesize SeNPs within a broad range of temperature (i.e. 18 to 40 °C) and pH (i.e. 5 to 10). Although MTC for the strain GUSDM4 was recorded to be 100 mM the nanoparticle synthesis was not carried at such a high concentration since it is a well-known fact that nanoparticles at high salt concentrations tend to aggregate forming particles with a larger diameter which is undesirable (Stoeva et al. 2002). Earlier studies on SeNPs biosynthesis by marine Bacillus sp. MSh-1 demonstrated that biosynthesis was initiated after 14 h of incubation (Forootanfar et al. 2014). Therefore, our strain GUSDM4 is very efficient in the biosynthesis of SeNPs.
Characterization of biosynthesized nanoparticles
The UV-Vis spectrophotometry analysis clearly revealed an absorbance peak of brick red colloidal solution at 265 nm due to surface plasmon resonance indicating the presence of SeNPs (Fig. 5a). The XRD analysis revealed characteristic Bragg’s peaks at 23.46, 29.76 and 43.72, corresponding to [100], [101] and [110] lattices of hexagonal Se respectively (ICDD-card no.06-0362). The average size of the crystal domain was calculated to be 37.27 nm (Fig. 5b). TEM micrographs of SeNPs revealed spherical morphology with size ranging from 20 to 80 nm (Fig. 5d). The EDAX analysis demonstrated the absorption peaks at 1.5, 11.2 and 12.5 KeV thus, further reiterating presence of elemental Se (Fig. 5c).
The characterization of SeNPs using XRD, TEM and EDAX analysis confirmed the presence of pure spherical SeNPs exhibiting hexagonal crystal lattice with a diameter in the range of 20-80 nm. Previously, Zooglea ramigera has been reported to biosynthesize spherical SeNPs with diameter ranging from 30 to 130 nm (Srivastava and Mukhopadhyay 2013). Similarly, in another study size distribution of 200-400 nm was observed using the halophilic bacteria B. selenitriducens, S. shriftii and S. barnesii (Oremland et al. 2007). Size of NPs plays a major role in determining the functions of nanoparticles, smaller the size greater are the chances of enhancing its functionality and efficiency.
Applications of biogenic SeNPs
Anti-oxidant activity
Biogenic SeNPs exhibited excellent dose-dependent anti-oxidant activity. An increasing percent free radical scavenging activity with increasing concentrations of SeNPs was recorded (Fig. 6). For instance, the percent scavenging activity at 25 µg/mL of biogenic SeNPs was recorded 50% while 90% at 50 µg/mL.
The biogenic SeNPs interestingly demonstrated 90% free radical scavenging activity at 50 µg/mL. Higher antioxidant activity of SeNPs is mainly due to the presence of seleno-enzymes viz. glutathione peroxidase and thioredoxin reductase, which are known to play a pivotal role in preventing the free radicals. Previous findings on anti-oxidant activity by biogenic SeNPs also showed a similar dose-dependent trend but at higher concentrations i.e. 100 to 1000 µg/mL. In this case, the percent scavenging activity at 100 µg/mL was 80%, while at 1000 µg/mL the activity was 100% (Ramya et al. 2015). However, the current study demonstrated approximately 90% free radical scavenging activity at 50 µg/mL SeNPs which is highly significant. Moreover, another study demonstrated 23.1 ± 3.4 % free radical scavenging activity at 200 µg/mL SeNPs (Forootanfar et al. 2014). Differences in the % free radical scavenging activity may be attributed to the difference in the size of biosynthesized nanoparticles with the fact that smaller particles are known to exhibit greater free radical scavenging activity as compared to larger aggregates (Torres et al. 2012).
Anti-biofilm activity
SeNPs demonstrated dose-dependent anti-biofilm activity against Gram-positive and Gram-negative bacterial pathogens (Fig. 7a). Highest anti-biofilm activity was recorded against K. pneumonia at 20 (39.45 %), 25 (55.89 %) and 50 (90.96 %) µg/mL. This was followed by E. coli in which 38.56, 48.58 and 78.26 % inhibition of biofilm was observed. Whereas, in Gram-positive, S. aureus 18.89, 35.89 and 60.89 % inhibition was observed while in S. pyogenes inhibition was 9.58, 18.56 and 55.89 % at 20, 25 and 50 µg/mL respectively. Further, SEM images clearly revealed dislodging of bacterial biofilms along with morphological alterations in the form of surface depressions with increasing concentrations of SeNPs (Fig. 7b). SeNPs also exhibited excellent anti-biofilm activity against four potential biofilm forming bacterial strains. The highest anti-biofilm activity was observed against K. pneumoniae followed by E. coli, S. aureus and S. pyogenes. Previously, a similar % reduction of S. aureus, P. aeruginosa and P. Mirabilis biofilms were reported (Shakibaie et al. 2015). These results also corroborated with the SEM analysis demonstrating the dislodging of bacterial biofilms. This opens a new arena of applications for SeNPs as coating agents in medical and health-related devices in order to prevent bacterial infections caused by biofilm forming bacteria. Likewise, these SeNPs may also have promising applications in industrial sectors as potential tools to combat biofouling. In addition, they can also serve as excellent candidates to eradicate biofilm formation in sewage tanks and other sewerage systems.
Anti-cancer activity
Dose-dependent toxicity of SeNPs towards cancer cells was very much evident. SeNPs were very effective in inhibiting the A549 cell lines at concentrations as low as 10 µg/mL while at 70 µg/mL complete mortality was observed (Fig. 8a). Interestingly, SeNPs were ineffective against normal human bronchial epithelial cells (BEAS-2B) as no mortality was observed. We have also clearly observed effect of SeNPs on cancer cell line using electron microscopy (Fig. 8 b, c, d, e). The untreated A549 cells were highly dense, confluent and abundant. However, after treatment with SeNPs large cells have circularized and shrunk showing decrease in density and adherence of cells.
Biogenic SeNPs exhibited excellent dose-dependent anti-cell proliferative characteristics at low doses. At 70 µg/mL complete mortality of A549 human lung cancer cell line was observed. Although, selenium compounds viz. selenite, selenate, selenomethionine, selenocysteine and methyl-selenocysteine are known to be anti-carcinogenic the concentrations at which these compounds are effective is very high and toxic (Zhang et al. 2007; Seng and Tiekink 2012). SeNPs have attracted considerable attention due to its exceptional biological potential and reduced toxicity (Luo et al. 2012). Biogenic SeNPs have been reported for its anticancer activity and are found to be effective against various cancer cell lines viz. MCF-7/breast adenocarcinoma, MDA-MB-231/human breast carcinoma, A375/ human melanoma, LNcaP/prostrate, HK-2/human kidney, HepG2/liver hepatocellular carcinoma cell lines and HeLa/human cervical carcinoma (Chen et al. 2008; Kong et al. 2011; Zheng et al. 2011; Luo et al. 2012; Ramya et al. 2015). The high specificity of SeNPs to the cancer cells may be due to the difference in anti-oxidant enzyme regulations which are over-expressed in case of cancer cells (Fang et al. 2005). Morphological alterations in SeNPs treated cells were also eveident of its anti-cell proliferative activity. Similar morphological alterations in Hela cells and MDA-MB-231 cells have been reported earlier in the presence of selenium nanoparticles by Luo et al. (2012). Keeping in view the nonspecificity and adverse effects of present chemotherapeutic treatments, use of these highly specific Se-nano-therapeutics would be the best alternative.
Mosquito larvicidal activity
SeNPs exhibited larvicidal activity against all three tested spp. of mosquito as evident from LC50 and LC90 values of SeNPs against laboratory-reared larvae of An. stephensi, Cx. quinquefasciatus and Ae. Aegypti (Table 1). Among all the mosquito spp. tested, highest larval mortality (after 24 and 48 h of post-treatment) was recorded for Cx. quinquefasciatus with LC50 of 29.92 and 24.8 ppm respectively, trailed by Ae. aegypti with LC50 of 50.37 and 44.5 ppm and An. stephensi with LC50 of 59.18 and 58.41 ppm respectively.
SeNPs also revealed the dose dependent larvicidal potential against mosquito spp. SeNPs were most effective against Cx. quinquefasciatus followed by Ae. Aegypti and An. stephensi. Previously, SeNPs synthesized from leaf extract of C. dentata was reported to exhibit LC50 of 240.714 ppm, 104.13 ppm and 99.602 ppm for An. stephensi, Ae. Aegypti and Cx. quinquefasciatus respectively (Sowndarya et al. 2017). However, the reported doses have LC50 values at much higher concentrations than the current study, which is almost 4.1, 2.34 and 4 fold higher for An. stephensi, Ae. Aegypti and Cx. quinquefasciatus respectively. The microscopic images of the test and control larvae revealed that SeNPs are showing toxicity once the nanoparticles are internalised by the larvae (Supplementary Fig. 4).
The vector control strategies mainly target adults or larvae and largely involve the use of chemical insecticides. The repetitive use of these hazardous insecticides foster various complications which mainly include development of insecticide-resistance, natural biological control system disruption, outburst of other insects and undesired effect on non-target insect spp. (Yang et al. 2002). The advantages associated with larval control include low mortalities and effective coverage due to behavioural responses of immature mosquito. Nanoparticle-based approach can be most desired due to its specificity and effectiveness at low concentrations. Thus, the use of biogenic SeNPs as a mosquito larvicidal agent would be much favourable.
Table 1: Larvicidal activity of biogenic SeNPs against An. stephensi, Ae. Aegypti and Cx. quinquefasciatus.
Mosquito spp.
|
24 h
|
48 h
|
LC50
(lower and upper limit)
|
LC90
(lower and upper limit)
|
LC50
(lower and upper limit)
|
LC90
(lower and upper limit)
|
Anopheles stephensi
|
59.189
(44.753-78.282)
|
141.163
(106.734-186.699)
|
58.410
(44.156-77.265)
|
140.500
(106.500-185.856)
|
Aedes aegypti
|
50.378
(35.081-72.345)
|
159.076
(110.773-228.441)
|
44.506
(32.004-61.892)
|
129.488
(93.114-180.079)
|
Culex quinquefasciatus
|
29.925
(20.838-42.977)
|
87.734
(61.091-125.997)
|
24.800
(16.678-36.8790)
|
82.383
(558.401-122.505)
|